BHC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price

$7.03

Market Cap

$2.60B

P/E (TTM)

16.7

EPS (TTM)

$0.42

Revenue (TTM)

$10.27B

Div Yield

—

ROE

-17.1%

Debt/Equity

-37.6

52W Range

$4 – $8

BHC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $10.27B

2016-12-31 → 2025-12-31

EPS $0.42

2016-12-31 → 2025-12-31

Free Cash Flow $1.00B

2016-12-31 → 2025-12-31

Margins 1.5%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric

5Y trend

BHC

Peer Median

P/E (TTM)

16.7

12.7

P/S (TTM)

0.3

0.6

P/B

-4.7

0.6

EV / EBITDA

12.2

—

Price / FCF

2.6

—

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric

5Y trend

BHC

Peer Median

Operating Margin

17.7%

—

Net Profit Margin

1.5%

-9.7%

ROA

0.59%

-7.0%

ROE

-17.1%

-92.8%

ROIC

2.9%

—

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric

5Y trend

BHC

Peer Median

Debt / Equity

-37.6

16.7

Current Ratio

1.5

2.6

Quick Ratio

0.9

—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric

5Y trend

BHC

Peer Median

Revenue YoY

6.7%

—

Revenue CAGR 3Y

8.1%

—

Revenue CAGR 5Y

5.0%

—

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric

5Y trend

BHC

Peer Median

EPS (Diluted)

$0.42

—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric

5Y trend

BHC

Peer Median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

Dividend Yield

—

Payout Ratio

—

5Y Div CAGR

—

Ex-date	Amount
Nov. 10, 2010	$1.0000
Aug. 30, 2010	$0.0950
May 28, 2010	$0.0950
March 4, 2010	$0.0900
Nov. 30, 2009	$0.0900
Aug. 28, 2009	$0.0900
May 13, 2009	$0.0900
March 6, 2009	$0.3750
Dec. 19, 2008	$0.3750
Aug. 21, 2008	$0.3750
May 20, 2008	$0.3750
March 25, 2008	$0.3750
Nov. 16, 2007	$0.3750
Aug. 16, 2007	$0.3750
May 18, 2007	$0.3750
March 22, 2007	$0.3750
Jan. 8, 2007	$0.5000
Nov. 20, 2006	$0.1250
Aug. 16, 2006	$0.1250
May 19, 2006	$0.1250

BHC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

SELL 8 analysts

Strong Buy 0 0.0%
Buy 0 0.0%
Hold 4 50.0%
Sell 3 37.5%
Strong Sell 1 12.5%

12-Month Price Target

5 analysts · 2026-08-15

Median $7.00

Mean $7.50

Now $7.03

Low $6.50

High $9.00

Median target $7.00 -0.4%

Mean target $7.50 +6.7%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise

-0.02%

Period	EPS Actual	EPS Est	Surprise
June 30, 2026	$1.26	$1.05	0.21%
March 31, 2026	$0.78	$0.69	0.09%
Dec. 31, 2025	$1.10	$1.28	-0.18%
Sept. 30, 2025	$1.16	$1.13	0.03%
June 30, 2025	$0.91	$0.98	-0.07%
March 31, 2025	$0.60	$0.80	-0.20%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
BHC	$2.58B	16.5	6.7%	1.5%	-17.1%	—
TLRY	$726M	-5.1	11.5%	-13.3%	-7.8%	28.4%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 15

Annual Income Statement data for BHC
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$10.27B	$9.62B	$8.76B	$8.12B	$8.43B	$8.03B	$8.60B	$8.38B	$8.72B	$9.67B	$10.45B	$8.21B
Cost of Revenue	·	·	·	·	·	·	·	·	$2.51B	$2.57B	$2.53B	$2.18B
SG&A Expense	$3.44B	$3.30B	$2.92B	$2.62B	$2.62B	$2.37B	$2.55B	$2.47B	$2.58B	$2.81B	$2.70B	$2.03B
Operating Expenses	$8.45B	$8.08B	$7.79B	$7.67B	$7.98B	$7.35B	$8.80B	$10.76B	$8.62B	$10.24B	$8.92B	$6.21B
Operating Income	$1.81B	$1.55B	$963M	$454M	$450M	$676M	$-203M	$-2.38B	$102M	$-566M	$1.53B	$2.00B
Interest Income	$48M	$33M	$26M	$14M	$7M	$13M	$12M	$11M	$12M	$8M	$4M	$5M
Other Non-op	$-142M	$-247M	$-28M	$-35M	$-373M	$-502M	$-1.43B	$20M	$348M	$-73M	$-295M	$263M
Pretax Income	$367M	$167M	$-390M	$-129M	$-1.02B	$-934M	$-1.84B	$-4.15B	$-1.74B	$-2.44B	$-155M	$1.05B
Income Tax	$247M	$239M	$221M	$83M	$-87M	$-375M	$-54M	$-10M	$-4.14B	$-27M	$133M	$174M
Net Income	$157M	$-46M	$-592M	$-225M	$-948M	$-560M	$-1.79B	$-4.14B	$2.40B	$-2.41B	$-288M	$880M
EPS (Basic)	$0.42	$-0.13	$-1.62	$-0.62	$-2.64	$-1.58	$-5.08	$-11.81	$6.86	$-6.94	$-0.85	$2.63
EPS (Diluted)	$0.42	$-0.13	$-1.62	$-0.62	$-2.64	$-1.58	$-5.08	$-11.81	$6.83	$-6.94	$-0.85	$2.58
Shares (Basic)	370,900,000	368,000,000	364,900,000	362,000,000	358,900,000	355,000,000	352,100,000	351,300,000	350,200,000	347,300,000	342,700,000	335,400,000
Shares (Diluted)	375,000,000	368,000,000	364,900,000	362,000,000	358,900,000	355,000,000	352,100,000	351,300,000	351,800,000	347,300,000	342,700,000	341,500,000
EBITDA	$1.81B	$1.55B	$963M	$454M	$450M	$676M	$-203M	$-2.38B	$102M	$-566M	$1.53B	$2.04B

Balance Sheet 28

Annual Balance Sheet data for BHC
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$1.31B	$1.18B	$947M	$564M	$582M	$605M	$3.24B	$721M	$720M	$542M	$597M	$323M
Receivables	$2.35B	$2.14B	$2.00B	$1.79B	$1.77B	$1.58B	$1.84B	$1.86B	$2.13B	$2.52B	$2.69B	$2.08B
Inventory	$1.63B	$1.59B	$1.54B	$1.09B	$993M	$1.09B	$1.11B	$934M	$1.05B	$1.06B	$1.26B	$889M
Prepaid Expense	$852M	$838M	$1.09B	$776M	$720M	$855M	$779M	$689M	$771M	$696M	$963M	$651M
Current Assets	$6.16B	$5.77B	$5.60B	$4.25B	$5.61B	$5.34B	$6.97B	$4.21B	$4.75B	$5.08B	$5.51B	$4.13B
PP&E (Net)	$2.07B	$1.78B	$1.71B	$1.60B	$1.60B	$1.57B	$1.47B	$1.35B	$1.40B	$1.31B	$1.44B	$1.31B
PP&E (Gross)	$4.50B	$3.92B	$3.79B	$3.52B	$3.42B	$3.35B	$3.11B	$2.88B	$2.83B	$2.51B	$2.63B	$2.29B
Accum. Depreciation	$2.42B	$2.14B	$2.08B	$1.92B	$1.82B	$1.78B	$1.64B	$1.52B	$1.43B	$1.20B	$1.18B	$978M
Goodwill	$11.27B	$11.09B	$11.18B	$11.55B	$12.46B	$13.04B	$13.13B	$13.14B	$15.59B	$15.79B	$18.55B	$9.36B
Intangibles	$4.64B	$5.55B	$6.46B	$5.80B	$6.95B	$8.45B	$10.20B	$12.00B	$15.21B	$18.88B	$23.08B	$11.28B
Other Non-current Assets	$378M	$363M	$307M	$326M	$340M	$664M	$411M	$109M	$111M	$184M	$224M	$167M
Total Assets	$26.37B	$26.52B	$27.35B	$25.69B	$29.20B	$31.20B	$33.86B	$32.49B	$37.50B	$43.53B	$48.97B	$26.30B
Accounts Payable	$600M	$589M	$719M	$521M	$407M	$337M	$503M	$411M	$365M	$324M	$434M	$398M
Accrued Liabilities	$3.34B	$3.49B	$3.13B	$2.99B	$4.79B	$4.58B	$4.51B	$3.20B	$3.69B	$3.23B	$3.86B	$2.16B
Short-term Debt	·	·	·	·	·	·	·	·	·	$6M	$16M	$6M
Current Liabilities	$4.18B	$6.75B	$4.30B	$3.94B	$5.20B	$4.91B	$6.25B	$3.84B	$4.27B	$3.61B	$5.31B	$2.71B
Capital Leases	$167M	$165M	$148M	$184M	$214M	$227M	$240M	·	·	·	·	·
Deferred Tax	$147M	$128M	$163M	$202M	$529M	$528M	$705M	$885M	$1.18B	$5.43B	$5.90B	$2.22B
Other Non-current Liabilities	$793M	$713M	$776M	$741M	$653M	$1.01B	$851M	$581M	$526M	$486M	$185M	$197M
Total Liabilities	$25.99B	$26.84B	$27.43B	$25.43B	$29.24B	$30.59B	$32.73B	$29.68B	$31.55B	$40.27B	$42.94B	$20.90B
Long-term Debt	$20.82B	$21.62B	$22.39B	$20.77B	$22.65B	$23.93B	$25.89B	$24.30B	$25.44B	$29.85B	$31.09B	$15.23B
Total Debt	$20.82B	$21.62B	$22.39B	$20.77B	$22.65B	$23.93B	$25.89B	$24.30B	$25.44B	$29.85B	$31.10B	$15.26B
Common Stock	$10.52B	$10.49B	$10.42B	$10.39B	$10.32B	$10.23B	$10.17B	$10.12B	$10.09B	$10.04B	$9.90B	$8.35B
Retained Earnings	$-9.67B	$-9.82B	$-9.78B	$-9.19B	$-8.96B	$-8.01B	$-7.45B	$-5.66B	$-2.73B	$-5.13B	$-2.75B	$-2.40B
AOCI	$-1.76B	$-2.18B	$-1.88B	$-2.06B	$-1.92B	$-2.13B	$-2.09B	$-2.14B	$-1.90B	$-2.11B	$-1.54B	$-916M
Stockholders' Equity	$-554M	$-1.28B	$-1.02B	$-692M	$-106M	$535M	$1.06B	$2.73B	$5.85B	$3.15B	$5.91B	$5.28B
Liabilities + Equity	$26.37B	$26.52B	$27.35B	$25.69B	$29.20B	$31.20B	$33.86B	$32.49B	$37.50B	$43.53B	$48.97B	$26.30B
Shares Outstanding	370,531,987	367,843,058	365,238,917	361,898,846	359,405,748	355,422,347	352,562,636	349,871,102	348,708,567	347,821,606	342,926,531	334,402,964

Cash Flow 16

Annual Cash Flow data for BHC
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$1.21B	$1.27B	$1.26B	$1.39B	$1.55B	$1.82B	$2.08B	$2.82B	$2.86B	$2.87B	$2.47B	$1.61B
Stock-based Comp	$216M	$150M	$132M	$126M	$128M	$105M	$102M	$87M	$87M	$165M	$140M	$78M
Deferred Tax	$132M	$69M	$6M	$-188M	$-36M	$-599M	$-182M	$-337M	$-4.31B	$-268M	$56M	$23M
Restructuring	·	·	·	·	·	$22M	$31M	$22M	$52M	$132M	$362M	$382M
Operating Cash Flow	$1.40B	$1.60B	$1.03B	$-728M	$1.43B	$1.11B	$1.50B	$1.50B	$2.29B	$2.09B	$2.26B	$2.31B
CapEx	$397M	$337M	$215M	$218M	$269M	$302M	$270M	$157M	$171M	$235M	$235M	$292M
Investing Cash Flow	$-595M	$-454M	$-2.15B	$-303M	$409M	$-261M	$-419M	$-196M	$2.89B	$-125M	$-15.58B	$-100M
Debt Issued	$10.55B	$661M	$3.29B	$6.84B	$2.10B	$3.46B	$5.96B	$8.94B	$9.42B	$1.22B	$17.82B	$1.63B
Net Debt Issued	$-637M	$-799M	$1.58B	$-1.01B	$-1.34B	$-2.19B	$1.55B	$-1.16B	$-4.78B	$-1.22B	$15.76B	$-2.26B
Stock Issued	·	·	·	·	·	·	·	·	$0	$0	$1.43B	$0
Stock Repurchased	·	·	·	·	·	·	·	·	$0	$0	$72M	$0
Net Stock Activity	·	·	·	·	·	·	·	·	$0	$0	$1.36B	$0
Financing Cash Flow	$-742M	$-868M	$1.48B	$-474M	$-1.51B	$-2.29B	$1.44B	$-1.35B	$-4.96B	$-1.96B	$13.62B	$-2.46B
Net Change in Cash	$124M	$239M	$371M	$-1.53B	$303M	$-1.43B	$2.52B	$-74M	$255M	$-55M	$274M	·
Taxes Paid	$163M	·	·	·	·	·	·	·	·	·	·	·
Free Cash Flow	$1.00B	$1.26B	$817M	$-946M	$1.16B	$809M	$1.23B	$1.34B	$2.12B	$1.85B	$1.97B	$2.00B

Profitability 7

Annual Profitability data for BHC
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	17.7%	16.1%	11.0%	5.6%	5.3%	8.4%	-2.4%	-28.4%	1.2%	-5.9%	14.6%	24.7%
Net Margin	1.5%	-0.48%	-6.8%	-2.8%	-11.2%	-7.0%	-20.7%	-49.5%	27.6%	-24.9%	-2.8%	11.0%
Pretax Margin	3.6%	1.7%	-4.5%	-1.6%	-12.1%	-11.6%	-21.4%	-49.6%	-20.0%	-25.2%	-1.5%	13.2%
EBITDA Margin	17.7%	16.1%	11.0%	5.6%	5.3%	8.4%	-2.4%	-28.4%	1.2%	-5.9%	14.6%	24.7%
ROA	0.59%	-0.17%	-2.2%	-0.82%	-3.1%	-1.7%	-5.4%	-11.8%	5.9%	-5.2%	-0.76%	3.4%
ROE	-17.1%	4.0%	69.1%	56.4%	-442.0%	-70.0%	-93.9%	-114.0%	53.4%	-53.1%	-5.1%	17.5%
ROIC	2.9%	-3.3%	7.1%	3.7%	1.8%	1.7%	-0.73%	-8.8%	-0.45%	-1.7%	7.6%	8.3%

Liquidity & Solvency 4

Annual Liquidity & Solvency data for BHC
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	1.5	0.9	1.3	1.1	1.1	1.1	1.1	1.1	1.1	1.4	1.0	1.5
Quick Ratio	0.9	0.5	0.7	0.6	0.5	0.4	0.8	0.7	0.7	0.8	0.6	0.9
Debt / Equity	-37.6	-16.9	-21.9	-30.0	-213.7	44.7	24.4	8.9	4.4	9.5	5.3	2.9
LT Debt / Equity	-37.2	-14.8	-21.5	-29.4	-213.7	44.7	23.2	8.8	4.3	9.5	5.1	2.9

Efficiency 3

Annual Efficiency data for BHC
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.4	0.4	0.3	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.3	0.3
Inventory Turnover	·	·	·	·	·	·	·	·	2.4	2.2	2.4	2.4
Receivables Turnover	4.6	4.7	4.6	4.6	5.0	4.7	4.6	4.2	3.8	3.7	4.4	4.4

Per Share 5

Annual Per Share data for BHC
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$-1.50	$-3.48	$-2.80	$-1.91	$-0.29	$1.51	$3.02	$7.81	$16.77	$9.06	$17.24	$15.89
Revenue / Share	$27.38	$26.15	$24.00	$22.44	$23.50	·	$24.43	$23.85	$24.80	$27.85	$30.48	$24.20
Cash Flow / Share	$3.73	$4.34	$2.83	$-2.01	$3.97	·	$4.26	$4.27	$6.51	$6.01	$6.42	$6.72
Cash / Share	$3.53	$3.21	$2.59	$1.56	$1.62	$1.70	$9.20	$2.06	$2.06	$1.56	$1.74	$0.96
EPS (TTM)	$0.42	$-0.13	$-1.62	$-0.62	$-2.64	$-1.58	$-5.08	$-11.81	$6.83	$-6.94	$-0.85	$2.58

Growth Rates 3

Annual Growth Rates data for BHC
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	6.7%	9.9%	7.8%	-3.7%	5.1%	·	·	·	·	·	·	·
Revenue CAGR 3Y	8.1%	4.5%	2.9%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	5.0%	·	·	·	·	·	·	·	·	·	·	·

Valuation (TTM) 13

Annual Valuation (TTM) data for BHC
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$10.27B	$9.62B	$8.76B	$8.12B	$8.43B	$8.03B	$8.60B	$8.38B	$8.72B	$9.67B	$10.45B	$8.21B
Net Income TTM	$157M	$-46M	$-592M	$-225M	$-948M	$-560M	$-1.79B	$-4.14B	$2.40B	$-2.41B	$-288M	$880M
Market Cap	$2.58B	$2.96B	$2.93B	$2.27B	$9.92B	$7.39B	$10.55B	$6.46B	$7.25B	$5.05B	$34.86B	$47.86B
Enterprise Value	$22.08B	$23.40B	$24.37B	$22.47B	$32.00B	$30.71B	$33.20B	$30.05B	$31.97B	$34.36B	$65.37B	$62.79B
P/E	16.5	-62.0	-5.0	-10.1	-10.5	-13.2	-5.9	-1.6	3.0	-2.1	-119.6	55.5
P/S	0.3	0.3	0.3	0.3	1.2	0.9	1.2	0.8	0.8	0.5	3.3	5.8
P/B	-4.6	-2.3	-2.9	-3.3	-93.6	13.8	9.9	2.4	1.2	1.6	5.9	9.0
P / Cash Flow	1.8	1.9	2.8	-3.1	7.0	6.7	7.0	4.3	3.2	2.4	15.8	20.9
P / FCF	2.6	2.4	3.6	-2.4	8.6	9.1	8.6	4.8	3.4	2.7	17.7	23.9
EV / EBITDA	12.2	15.1	25.3	49.5	71.1	45.4	-163.6	-12.6	313.4	-60.7	42.8	30.8
EV / FCF	22.0	18.6	29.8	-23.8	27.7	38.0	27.0	22.4	15.1	18.6	33.3	31.3
EV / Revenue	2.2	2.4	2.8	2.8	3.8	3.8	3.9	3.6	3.7	3.6	6.3	7.7
Earnings Yield	6.0%	-1.6%	-20.2%	-9.9%	-9.6%	-7.6%	-17.0%	-63.9%	32.9%	-47.8%	-0.84%	1.8%

Income Statement 14

Quarterly Income Statement data for BHC
Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$2.85B	$2.52B	$2.80B	$2.68B	$2.53B	$2.26B	$2.56B	$2.51B	$2.40B	$2.15B	$2.41B	$2.24B	$2.17B	$1.94B	$2.19B	$2.05B
SG&A Expense	$907M	$861M	$882M	$795M	$894M	$867M	$820M	$850M	$832M	$794M	$766M	$715M	$711M	$725M	$666M	$661M
Operating Expenses	$2.11B	$3.47B	$2.32B	$2.06B	$2.09B	$1.98B	$2.00B	$2.19B	$2.01B	$1.87B	$2.05B	$2.22B	$1.75B	$1.77B	$2.43B	$1.80B
Operating Income	$740M	$-950M	$474M	$619M	$444M	$276M	$558M	$318M	$389M	$281M	$362M	$14M	$412M	$175M	$-236M	$244M
Interest Income	$11M	$10M	$9M	$15M	$13M	$11M	$9M	$7M	$8M	$9M	$7M	$6M	$7M	$6M	$6M	$3M
Other Non-op	·	·	·	·	·	·	$-2M	$-225M	$-20M	$0	$-28M	$-60M	$83M	$-23M	$-29M	$-4M
Pretax Income	$348M	$-1.35B	$56M	$218M	$140M	$-47M	$209M	$-21M	$48M	$-69M	$-7M	$-326M	$79M	$-136M	$-357M	$439M
Income Tax	$88M	$77M	$159M	$37M	$12M	$39M	$111M	$71M	$49M	$8M	$40M	$56M	$52M	$73M	$53M	$36M
Net Income	$258M	$-1.42B	$-112M	$179M	$148M	$-58M	$93M	$-85M	$10M	$-64M	$-39M	$-378M	$26M	$-201M	$-410M	$399M
EPS (Basic)	$0.69	$-3.82	$-0.30	$0.48	$0.40	$-0.16	$0.24	$-0.23	$0.03	$-0.17	$-0.11	$-1.03	$0.07	$-0.55	$-1.13	$1.10
EPS (Diluted)	$0.68	$-3.82	$-0.30	$0.48	$0.40	$-0.16	$0.24	$-0.23	$0.03	$-0.17	$-0.11	$-1.03	$0.07	$-0.55	$-1.13	$1.10
Shares (Basic)	375,000,000	372,800,000	-740,900,000	371,300,000	370,900,000	369,600,000	-735,100,000	368,400,000	367,900,000	366,800,000	-728,600,000	365,400,000	364,800,000	363,300,000	-723,500,000	362,500,000
Shares (Diluted)	378,100,000	372,800,000	-743,200,000	375,500,000	373,100,000	369,600,000	-737,400,000	368,400,000	370,200,000	366,800,000	-730,900,000	365,400,000	367,100,000	363,300,000	-724,400,000	363,400,000
EBITDA	$740M	$-950M	·	$619M	$444M	$276M	·	$318M	$389M	$281M	·	$14M	$412M	$175M	·	$244M

Balance Sheet 27

Quarterly Balance Sheet data for BHC
Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$1.82B	$1.30B	$1.31B	$1.31B	$1.73B	$1.13B	$1.18B	$719M	$595M	$733M	$947M	$760M	$579M	$518M	$564M	$486M
Receivables	$2.26B	$2.19B	$2.35B	$2.42B	$2.21B	$2.07B	$2.14B	$2.09B	$2.10B	$2.05B	·	$1.95B	$1.74B	$1.69B	·	$1.74B
Inventory	$1.60B	$1.60B	$1.63B	$1.60B	$1.66B	$1.61B	$1.59B	$1.66B	$1.61B	$1.64B	·	$1.27B	$1.24B	$1.22B	·	$1.06B
Prepaid Expense	$819M	$874M	$852M	$894M	$906M	$890M	$838M	$852M	$874M	$957M	·	$1.05B	$890M	$796M	·	$718M
Current Assets	$6.52B	$5.98B	$6.16B	$6.25B	$6.51B	$5.73B	$5.77B	$5.35B	$5.21B	$5.40B	·	$5.05B	$4.46B	$4.24B	·	$4.01B
PP&E (Net)	·	·	$2.07B	$2.03B	$1.99B	$1.88B	$1.78B	$1.79B	$1.74B	$1.71B	·	$1.58B	$1.60B	$1.60B	·	$1.51B
PP&E (Gross)	·	·	$4.50B	·	·	·	$3.92B	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$2.42B	·	·	·	$2.14B	·	·	·	·	·	·	·	·	·
Goodwill	$9.79B	$9.81B	$11.27B	$11.29B	$11.30B	$11.15B	$11.09B	$11.17B	$11.13B	$11.16B	$11.18B	$11.19B	$11.63B	$11.58B	$11.55B	$12.04B
Intangibles	$4.18B	$4.40B	$4.64B	$4.83B	$5.05B	$5.30B	$5.55B	$5.65B	$5.90B	$6.18B	·	$6.73B	$5.30B	$5.55B	·	$6.02B
Other Non-current Assets	$358M	$369M	$378M	$382M	$388M	$380M	$363M	$389M	$329M	$312M	·	$328M	$325M	$318M	·	$341M
Total Assets	$24.79B	$24.50B	$26.37B	$26.82B	$27.27B	$26.42B	$26.52B	$26.54B	$26.50B	$26.91B	·	$27.06B	$25.50B	$25.45B	·	$26.30B
Accounts Payable	$593M	$593M	$600M	$616M	$627M	$620M	$589M	$667M	$579M	$642M	·	$569M	$515M	$561M	·	$486M
Accrued Liabilities	$3.07B	$3.04B	$3.34B	$3.60B	$3.47B	$3.35B	$3.49B	$3.39B	$3.34B	$3.23B	·	$3.12B	$3.01B	$2.92B	·	$2.93B
Current Liabilities	$4.54B	$4.53B	$4.18B	$4.79B	$4.97B	$4.26B	$6.75B	$4.51B	$4.37B	$4.41B	·	$4.22B	$3.97B	$3.92B	·	$3.83B
Capital Leases	·	·	$167M	·	·	·	$165M	·	·	·	·	·	·	·	·	·
Deferred Tax	$211M	$179M	$147M	$145M	$144M	$134M	$128M	$169M	$170M	$170M	·	$213M	$215M	$205M	·	$422M
Other Non-current Liabilities	$733M	$763M	$793M	$843M	$877M	$761M	$713M	$805M	$745M	$751M	·	$721M	$745M	$746M	·	$619M
Total Liabilities	$25.60B	$25.58B	$25.99B	$26.47B	$27.12B	$26.66B	$26.84B	$26.78B	$26.72B	$27.09B	·	$27.30B	$25.23B	$25.30B	·	$25.86B
Long-term Debt	$20.74B	$20.76B	$20.82B	$21.04B	$21.74B	$21.51B	$21.62B	$21.51B	$21.66B	$22.07B	·	$22.43B	$20.55B	$20.65B	·	$21.21B
Total Debt	$20.74B	$20.76B	·	$21.04B	$21.74B	$21.51B	·	$21.51B	$21.66B	$22.07B	·	$22.43B	$20.55B	$20.65B	·	$21.21B
Common Stock	$10.54B	$10.54B	$10.52B	$10.52B	$10.51B	$10.51B	$10.49B	$10.49B	$10.48B	$10.48B	·	$10.42B	$10.41B	$10.40B	·	$10.39B
Retained Earnings	$-10.83B	$-11.09B	$-9.67B	$-9.55B	$-9.73B	$-9.88B	$-9.82B	$-9.92B	$-9.83B	$-9.84B	·	$-9.74B	$-9.36B	$-9.39B	·	$-8.78B
AOCI	$-1.82B	$-1.81B	$-1.76B	$-1.80B	$-1.79B	$-2.03B	$-2.18B	$-1.95B	$-2.01B	$-1.92B	·	$-2.05B	$-1.90B	$-1.99B	·	$-2.27B
Stockholders' Equity	$-1.77B	$-2.06B	$-554M	$-565M	$-764M	$-1.18B	$-1.28B	$-1.17B	$-1.18B	$-1.11B	·	$-1.18B	$-663M	$-800M	·	$-525M
Liabilities + Equity	$24.79B	$24.50B	$26.37B	$26.82B	$27.27B	$26.42B	$26.52B	$26.54B	$26.50B	$26.91B	·	$27.06B	$25.50B	$25.45B	·	$26.30B
Shares Outstanding	373,901,440	373,464,760	370,531,987	370,473,221	369,749,489	369,539,455	367,843,058	367,695,267	366,985,967	366,674,264	·	365,043,317	364,063,514	363,607,062	·	361,781,292

Cash Flow 10

Quarterly Cash Flow data for BHC
Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$281M	$295M	$290M	$306M	$307M	$305M	$307M	$322M	$318M	$320M	$329M	$301M	$315M	$319M	$360M	$335M
Stock-based Comp	$54M	$52M	$84M	$43M	$46M	$43M	$43M	$38M	$36M	$33M	$29M	$29M	$33M	$41M	$35M	$33M
Operating Cash Flow	$670M	$230M	$495M	$405M	$289M	$211M	$601M	$405M	$380M	$211M	$390M	$282M	$206M	$154M	$475M	$-1.26B
CapEx	$77M	$109M	$92M	$91M	$99M	$115M	$106M	$71M	$78M	$82M	$98M	$42M	$28M	$47M	$66M	$54M
Investing Cash Flow	$-93M	$-139M	$-282M	$-83M	$-100M	$-130M	$-200M	$-102M	$-79M	$-73M	$-148M	$-1.89B	$-30M	$-78M	$-136M	$-53M
Debt Issued	$84M	$2.80B	$133M	$-1M	$10.37B	$50M	$506M	$0	$80M	$75M	$146M	$2.69B	$300M	$155M	$355M	$161M
Net Debt Issued	·	$-55M	·	·	·	$-118M	·	·	·	$-315M	·	·	·	$-124M	·	·
Financing Cash Flow	$-49M	$-100M	$-235M	$-719M	$358M	$-146M	$85M	$-189M	$-424M	$-340M	$-79M	$1.82B	$-120M	$-142M	$-276M	$-36M
Net Change in Cash	$526M	$-13M	$-15M	$-403M	$586M	$-44M	$451M	$127M	$-132M	$-207M	$182M	$192M	$57M	$-60M	$94M	$-1.38B
Free Cash Flow	·	$121M	·	·	·	$96M	·	·	·	$129M	·	·	·	$107M	·	·

Profitability 7

Quarterly Profitability data for BHC
Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	25.9%	-37.6%	·	23.1%	17.5%	12.2%	·	12.7%	16.2%	13.1%	·	0.63%	19.0%	9.0%	·	11.9%
Net Margin	9.0%	-56.4%	·	6.7%	5.9%	-2.6%	·	-3.4%	0.42%	-3.0%	·	-16.9%	1.2%	-10.3%	·	19.5%
Pretax Margin	12.2%	-53.6%	·	8.1%	5.5%	-2.1%	·	-0.84%	2.0%	-3.2%	·	-14.6%	3.6%	-7.0%	·	21.5%
EBITDA Margin	25.9%	-37.6%	·	23.1%	17.5%	12.2%	·	12.7%	16.2%	13.1%	·	0.63%	19.0%	9.0%	·	11.9%
ROA	0.99%	-5.6%	·	0.67%	0.55%	-0.22%	·	-0.32%	0.04%	-0.24%	·	-1.4%	0.10%	-0.74%	·	1.4%
ROE	-20.4%	87.8%	·	-20.6%	-15.3%	5.1%	·	7.2%	-1.1%	6.7%	·	44.3%	-3.8%	39.6%	·	-109.5%
ROIC	2.9%	-5.4%	·	2.5%	1.9%	2.5%	·	6.9%	-0.04%	1.5%	·	0.08%	0.71%	1.4%	·	1.1%

Liquidity & Solvency 4

Quarterly Liquidity & Solvency data for BHC
Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	1.4	1.3	·	1.3	1.3	1.3	·	1.2	1.2	1.2	·	1.2	1.1	1.1	·	1.0
Quick Ratio	0.9	0.8	·	0.8	0.8	0.8	·	0.6	0.6	0.6	·	0.6	0.6	0.6	·	0.6
Debt / Equity	-11.7	-10.1	·	-37.2	-28.5	-18.2	·	-18.3	-18.4	-19.8	·	-19.0	-31.0	-25.8	·	-40.4
LT Debt / Equity	-11.2	-9.7	·	-36.2	-27.3	-17.9	·	-17.9	-18.0	-19.3	·	-18.6	-30.3	-25.3	·	-39.6

Efficiency 2

Quarterly Efficiency data for BHC
Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Receivables Turnover		1.3	1.2	·	1.2	1.2	1.1	·	1.2	1.2	1.2	·	1.2	1.3	1.2	·	1.2

Per Share 5

Quarterly Per Share data for BHC
Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$-4.74	$-5.51	·	$-1.53	$-2.07	$-3.20	·	$-3.19	$-3.20	$-3.04	·	$-3.23	$-1.82	$-2.20	·	$-1.45
Revenue / Share	$7.54	$6.77	·	$7.14	$6.78	$6.11	·	$6.81	$6.49	$5.87	·	$6.12	$5.90	$5.35	·	$5.63
Cash Flow / Share	·	$0.62	·	·	·	$0.57	·	·	·	$0.58	·	·	·	$0.42	·	·
Cash / Share	$4.88	$3.48	·	$3.53	$4.67	$3.07	·	$1.96	$1.62	$2.00	·	$2.08	$1.59	$1.42	·	$1.34
EPS (TTM)	$-2.26	$-3.10	·	$0.49	$0.04	$-0.53	·	$-1.40	$-1.10	$-1.68	·	$-0.41	$0.22	$-0.04	·	$1.03

Valuation (TTM) 13

Quarterly Valuation (TTM) data for BHC
Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$10.59B	$9.99B	·	$9.98B	$9.70B	$9.32B	·	$9.30B	$8.96B	$8.50B	·	$8.39B	$8.12B	$7.88B	·	$8.04B
Net Income TTM	$-838M	$-1.15B	·	$184M	$15M	$-197M	·	$-517M	$-406M	$-617M	·	$-154M	$79M	$-16M	·	$373M
Market Cap	$1.84B	$2.02B	·	$2.39B	$2.46B	$2.39B	·	$3.00B	$2.56B	$3.89B	·	$3.00B	$2.91B	$2.95B	·	$2.49B
Enterprise Value	$20.76B	$21.48B	·	$22.12B	$22.47B	$22.77B	·	$23.79B	$23.62B	$25.23B	·	$24.67B	$22.89B	$23.08B	·	$23.22B
P/E	-2.2	-1.7	·	13.2	166.5	-12.2	·	-5.8	-6.3	-6.3	·	-20.0	36.4	-202.5	·	6.7
P/S	0.2	0.2	·	0.2	0.3	0.3	·	0.3	0.3	0.5	·	0.4	0.4	0.4	·	0.3
P/B	-1.0	-1.0	·	-4.2	-3.2	-2.0	·	-2.6	-2.2	-3.5	·	-2.5	-4.4	-3.7	·	-4.7
P / Cash Flow	·	8.8	·	·	·	11.3	·	·	·	18.4	·	·	·	19.1	·	·
P / FCF	·	16.7	·	·	·	24.9	·	·	·	30.2	·	·	·	27.5	·	·
EV / EBITDA	28.1	-22.6	·	35.7	50.6	82.5	·	74.8	60.7	89.8	·	1762.2	55.5	131.9	·	95.2
EV / FCF	·	177.5	·	·	·	237.2	·	·	·	195.6	·	·	·	215.7	·	·
EV / Revenue	2.0	2.1	·	2.2	2.3	2.4	·	2.6	2.6	3.0	·	2.9	2.8	2.9	·	2.9
Earnings Yield	-45.8%	-57.4%	·	7.6%	0.60%	-8.2%	·	-17.2%	-15.8%	-15.8%	·	-5.0%	2.8%	-0.49%	·	14.9%

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$10.27B	$9.62B	$8.76B	$8.12B	$8.43B
Operating Margin %	17.7%	16.1%	11.0%	5.6%	5.3%
Net Income	$157M	$-46M	$-592M	$-225M	$-948M
Diluted EPS	$0.42	$-0.13	$-1.62	$-0.62	$-2.64

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debt / Equity	-37.6	-16.9	-21.9	-30.0	-213.7
Current Ratio	1.5	0.9	1.3	1.1	1.1
Quick Ratio	0.9	0.5	0.7	0.6	0.5

Cash Flow

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$1.00B	$1.26B	$817M	$-946M	$1.16B

Latest News Recent headlines mentioning this company

Why Bausch Health Companies Was Crawling Higher This Week Nasdaq · 3 months, 2 weeks ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 264 filers · $1.1B total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
35 (+6 vs prior Q)	30 (0 vs prior Q)	79 (-11 vs prior Q)	66 (+7 vs prior Q)	+22.3M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
PAULSON & CO. INC.	$361,151,434	73,255,869	32.22%	Shares
GOLDENTREE ASSET MANAGEMENT LP	$170,706,865	34,665,731	15.23%	Shares
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	$39,440,000	8,000,000	3.52%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$36,797,292	7,465,468	3.28%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$32,979,314	4,764,873	2.94%	Shares
MFN Partners Management, LP	$29,580,000	6,000,000	2.64%	Shares
GOLDMAN SACHS GROUP INC	$29,197,792	5,922,473	2.60%	Shares
Kohlberg Kravis Roberts & Co. L.P.	$25,808,550	5,235,000	2.30%	Shares
ING GROEP NV	$24,650,000	5,000,000	2.20%	Shares
Hudson Bay Capital Management LP	$24,650,000	5,000,000	2.20%	Shares
Lombard Odier Asset Management (USA) Corp	$19,720,000	4,000,000	1.76%	Put option
NORGES BANK	$16,914,543	3,431,117	1.51%	Shares
ROYAL BANK OF CANADA	$16,445,000	3,335,713	1.47%	Shares
MACQUARIE GROUP LTD	$16,022,500	3,250,000	1.43%	Shares
GENDELL JEFFREY L	$14,927,404	3,027,871	1.33%	Shares
DIMENSIONAL FUND ADVISORS LP	$14,012,243	2,842,240	1.25%	Shares
D. E. Shaw & Co., Inc.	$12,484,879	2,533,096	1.11%	Shares
VANGUARD FIDUCIARY TRUST CO	$11,094,735	2,250,910	0.99%	Shares
Point72 Asset Management, L.P.	$11,021,637	2,235,821	0.98%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$10,771,345	2,186,244	0.96%	Shares
TWO SIGMA INVESTMENTS, LP	$10,528,419	2,135,582	0.94%	Shares
PRIVATE MANAGEMENT GROUP INC	$8,301,316	1,683,837	0.74%	Shares
Qube Research & Technologies Ltd	$8,291,856	1,681,918	0.74%	Shares
TWO SIGMA ADVISERS, LP	$7,366,576	1,059,939	0.66%	Shares
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	$7,365,406	1,494,205	0.66%	Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$6,903,479	1,400,300	0.62%	Put option
RENAISSANCE TECHNOLOGIES LLC	$6,530,027	1,324,549	0.58%	Shares
Man Group plc	$6,505,322	1,319,538	0.58%	Shares
BARCLAYS PLC	$6,162,500	1,250,000	0.55%	Put option
MILLENNIUM MANAGEMENT LLC	$5,394,096	1,095,104	0.48%	Shares
VANGUARD GROUP INC	$5,138,119	740,043	0.46%	Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$5,138,046	1,042,200	0.46%	Call option
DEUTSCHE BANK AG\	$4,930,000	1,000,000	0.44%	Call option
TD Asset Management Inc	$4,624,904	938,710	0.41%	Shares
BANK OF MONTREAL /CAN/	$4,396,480	892,927	0.39%	Shares
SIG North Trading, ULC	$4,360,585	884,500	0.39%	Call option
Bridgewater Associates, LP	$4,270,785	866,285	0.38%	Shares
Vanguard Global Advisers, LLC	$4,217,745	855,700	0.38%	Shares
O'SHAUGHNESSY ASSET MANAGEMENT, LLC	$3,712,320	753,006	0.33%	Shares
CITADEL ADVISORS LLC	$3,660,525	742,500	0.33%	Put option
GAMCO INVESTORS, INC. ET AL	$3,486,772	707,256	0.31%	Shares
WHITEBOX ADVISORS LLC	$3,030,333	614,672	0.27%	Shares
Jump Financial, LLC	$3,012,723	611,100	0.27%	Shares
WOLVERINE ASSET MANAGEMENT LLC	$2,680,441	543,700	0.24%	Put option
Trexquant Investment LP	$2,644,649	536,440	0.24%	Shares
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	$2,564,884	520,609	0.23%	Shares
MACKENZIE FINANCIAL CORP	$2,555,362	365,574	0.23%	Shares
Swiss National Bank	$2,498,689	508,460	0.22%	Shares
CANADA PENSION PLAN INVESTMENT BOARD	$2,418,350	491,168	0.22%	Shares
Federation des caisses Desjardins du Quebec	$2,391,971	496,238	0.21%	Shares
Quadrature Capital Ltd	$2,045,224	415,116	0.18%	Shares
NOMURA HOLDINGS INC	$1,969,141	399,420	0.18%	Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$1,942,204	394,378	0.17%	Shares
Nuveen Asset Management, LLC	$1,733,240	214,522	0.15%	Shares
Fore Capital, LLC	$1,725,500	350,000	0.15%	Call option
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	$1,610,228	327,038	0.14%	Shares
PICTON MAHONEY ASSET MANAGEMENT	$1,471,116	299,232	0.13%	Shares
WOLVERINE TRADING, LLC	$1,324,409	204,700	0.12%	Put option
CIBC Asset Management Inc	$1,305,024	265,310	0.12%	Shares
Walleye Trading LLC	$1,298,069	263,300	0.12%	Put option
Engineers Gate Manager LP	$1,232,456	249,991	0.11%	Shares
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$1,166,808	237,211	0.10%	Shares
NATIONAL BANK OF CANADA /FI/	$1,112,640	233,062	0.10%	Shares
VANGUARD ASSET MANAGEMENT, Ltd	$1,100,384	223,247	0.10%	Shares
Mitsubishi UFJ Trust & Banking Corp	$1,039,572	211,124	0.09%	Shares
Universal- Beteiligungs- und Servicegesellschaft mbH	$1,005,034	203,963	0.09%	Shares
WOLVERINE TRADING, LLC	$983,440	152,000	0.09%	Call option
Nuveen, LLC	$933,283	189,427	0.08%	Shares
BNP PARIBAS FINANCIAL MARKETS	$923,813	187,386	0.08%	Shares
VAN ECK ASSOCIATES CORP	$914,830	185,537	0.08%	Shares
RITHOLTZ WEALTH MANAGEMENT	$894,992	181,540	0.08%	Shares
Sequoia Financial Advisors, LLC	$879,019	178,300	0.08%	Call option
Caption Management, LLC	$827,747	167,900	0.07%	Put option
JANE STREET GROUP, LLC	$785,842	159,400	0.07%	Put option
Kazazian Asset Management, LLC	$739,500	150,000	0.07%	Shares
CIBC WORLD MARKET INC.	$725,182	147,267	0.06%	Shares
CITADEL ADVISORS LLC	$711,892	144,400	0.06%	Call option
AMERICAN CENTURY COMPANIES INC	$702,627	142,561	0.06%	Shares
FOX RUN MANAGEMENT, L.L.C.	$688,859	139,728	0.06%	Shares
TRUIST FINANCIAL CORP	$670,480	136,000	0.06%	Call option
Walleye Trading LLC	$666,531	135,199	0.06%	Shares
INTACT INVESTMENT MANAGEMENT INC.	$582,028	118,100	0.05%	Shares
SIG North Trading, ULC	$576,317	116,900	0.05%	Put option
Graham Capital Management, L.P.	$502,717	101,971	0.04%	Shares
Squarepoint Ops LLC	$501,568	101,738	0.04%	Shares
Y-Intercept (Hong Kong) Ltd	$458,830	93,069	0.04%	Shares
MARSHALL WACE, LLP	$453,787	92,046	0.04%	Shares
Zurcher Kantonalbank (Zurich Cantonalbank)	$438,349	88,971	0.04%	Shares
Vontobel Holding Ltd.	$426,322	86,475	0.04%	Shares
XTX Topco Ltd	$419,632	85,118	0.04%	Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$411,877	83,545	0.04%	Shares
Marex Group Ltd	$410,082	83,181	0.04%	Shares
Poehling Capital Management, INC.	$406,562	82,467	0.04%	Shares
AQR CAPITAL MANAGEMENT LLC	$405,837	82,424	0.04%	Shares
Fore Capital, LLC	$394,400	80,000	0.04%	Shares
Annis Gardner Whiting Capital Advisors, LLC	$392,936	79,703	0.04%	Shares
BlackRock, Inc.	$391,679	79,448	0.03%	Shares
CITADEL ADVISORS LLC	$391,334	79,378	0.03%	Shares
TRUIST FINANCIAL CORP	$387,118	78,523	0.03%	Shares
Schonfeld Strategic Advisors LLC	$386,549	78,408	0.03%	Shares

Company insiders 79 insiders · 37 officers · 40 directors

Insider	Role	Last activity	Shares owned	Buys 12m	Sells 12m	Net 12m
Thomas Appio	Chief Executive Officer	March 2, 2026 J	2,315,374	0	0	$0
Howard Bradley Schiller	Chairman and CEO	Feb. 18, 2016 F	336,784	0	0	$0
Michael J. Pearson	Chief Executive Officer	Dec. 31, 2015 F	1,514,664	0	0	$0
Jean-Jacques Charhon	EVP, CFO	Feb. 27, 2026 F	706,478	0	0	$0
Tom George Vadaketh	EVP, Chief Financial Officer	Sept. 5, 2023 F	564,933	0	0	$0
Sam Eldessouky	EVP & Chief Financial Officer	March 3, 2022 F	119,455	0	0	$0
Robert L. Rosiello	EVP, Chief Financial Officer	May 12, 2016 A	534,525	0	0	$0
Philip Walden Loberg Jr	EVP, Interim CFO	July 25, 2011 A	145,065	0	0	$0
Margaret Jean Mulligan	Chief Financial Officer	Oct. 4, 2010 A	—	0	0	$0
Aimee J. Lenar	President, US Pharma	July 17, 2026 F	371,680	0	0	$0
Robert Spurr	President, U.S. Businesses	May 10, 2022 M	112,741	0	0	$0
William D. Humphries	President, Ortho-Dermatologics	Dec. 4, 2020 M	235,035	0	0	$0
Mark C. Mckenna	President, Salix	Aug. 19, 2019 S	20,756	0	0	$0
Rajiv De Silva	President and COO	Jan. 5, 2013 F	259,767	0	0	$0
Richard Kevin Masterson	Pres. & COO, Valeant Intl. BB	May 10, 2012 S	89,524	0	0	$0
Michel Chouinard	COO, Biovail Labs. Intl SRL	Dec. 22, 2010 A	2,470	0	0	$0
Gilbert Godin	EVP & COO	July 5, 2010 A	—	0	0	$0
Steven Hyosig Lee	SVP, Controller & CAO	July 14, 2026 F	70,114	0	0	$0
Seana Carson	EVP, General Counsel	March 3, 2026 S	616,761	0	4	$-212,775
John S Barresi	SVP, Controller & CAO	Feb. 28, 2025 F	192,268	0	0	$0
Frederick Munsch	SVP, Controller and CAO	May 3, 2022 F	22,435	0	0	$0
Christina Ackermann	EVP AND GENERAL COUNSEL	March 10, 2022 F	162,240	0	0	$0
Joseph F Gordon	Pres&Co-Head Bausch&Lomb/Int'l	March 8, 2022 S	93,139	0	0	$0
Ari Kellen	EVP, Company Group Chairman	May 12, 2016 A	650,774	0	0	$0
Anne Clem Whitaker	EVP, Company Group Chairman	May 12, 2016 A	165,390	0	0	$0
Robert Roswell Chai-Onn	EVP, CLO, General Counsel	May 12, 2016 A	124,815	0	0	$0
Debora Jorn	EVP, Company Group Chairman	Nov. 20, 2015 F	34,812	0	0	$0
Pavel Mirovsky	EVP, Pres. & GM Valeant EMENA	June 23, 2015 A	69,525	0	0	$0
Brian M. Stolz	EVP, Administration & CHCO	June 22, 2015 F	125,280	0	0	$0
Laizer Kornwasser	EVP, Company Group Chairman	April 27, 2015 D	98,824	0	0	$0
Daniel Mark Wechsler	EVO, Co. Grp. Chmn, Eye Health	Aug. 12, 2013 A	—	0	0	$0
Susan Hall	Global Head of R&D	July 26, 2013 M	27,588	0	0	$0
Jason David Hanson	EVP, Company Group Chairman	Dec. 11, 2012 A	—	0	0	$0
Mark Andrew Durham	SVP Human Resources	May 11, 2011 M	61,595	0	0	$0
Christine Mayer	SVP, BTA Pharmaceuticals, Inc.	Oct. 4, 2010 A	—	0	0	$0
Hans Christian Fibiger	Chief Scientific Officer	Oct. 4, 2010 A	—	0	0	$0
Gregory David Gubitz	SVP, Corp. Devel. & GC	July 5, 2010 A	—	0	0	$0
Amy B Wechsler	Director	June 30, 2026 A	314,979	0	0	$0
John Paulson	Director	June 30, 2026 A	430,242	0	0	$0
Sandra Leung	Director	June 30, 2026 A	97,070	0	0	$0
Frank D. Lee	Director	May 22, 2026 A	95,210	0	2	$-254,682
Michael Goettler	Director	May 22, 2026 A	76,020	0	0	$0
Eiry Roberts	Director	May 22, 2026 A	45,871	0	0	$0
Sarah B Kavanagh	Director	May 22, 2026 A	282,230	0	0	$0
Christian A Garcia	Director	May 22, 2026 A	135,578	0	0	$0
Robert N Power	Director	May 22, 2026 A	300,594	0	0	$0
Brett Icahn	Director	June 30, 2025 A	220,280	0	0	$0
Steven D Miller	Director	May 16, 2025 A	229,224	0	0	$0
Richard Mulligan	Director	May 16, 2025 A	155,616	0	0	$0
Russel C Robertson	Director	March 29, 2024 A	225,279	0	0	$0
Thomas W. Ross Sr.	Director	May 19, 2023 A	161,516	0	0	$0
Richard U De Schutter	Director	March 31, 2023 A	373,407	0	0	$0
Argeris N Karabelas	Director	June 24, 2022 A	123,715	0	0	$0
Joseph C Papa	Director	May 10, 2022 M	1,427,568	0	0	$0
Fredric N Eshelman	Director	May 5, 2017 A	38,298	0	0	$0
Robert Alexander Ingram	Director	March 31, 2017 A	92,046	0	0	$0
Ronald Harold Farmer	Director	May 2, 2016 A	38,447	0	0	$0
Norma Ann Provencio	Director	May 2, 2016 A	144,899	0	0	$0
Kyriazi Theo Melas	Director	May 2, 2016 A	223,087	0	0	$0
Anders Lonner	Director	May 26, 2015 F	29,891	0	0	$0
Katharine Berghuis Stevenson	Director	May 22, 2015 A	24,705	0	0	$0
Colleen A Goggins	Director	May 22, 2015 A	4,973	0	0	$0
Fred Hassan	Director	Aug. 29, 2013 P	53,969	0	0	$0
Lloyd Mitchell Segal	Director	June 14, 2013 P	21,174	0	0	$0
Laurence E Paul	Director	June 1, 2012 P	60,459	0	0	$0
Michael Robert Van Every	Director	May 19, 2011 A	6,397	0	0	$0
William Mcdowall Wells	Director	Oct. 5, 2010 D	350,541	0	0	$0
Louis Randall Tull	Director	July 5, 2010 A	—	0	0	$0
Douglas John Paul Squires	Director	July 5, 2010 A	29,688	0	0	$0
John Spencer Lanthier	Director	July 5, 2010 A	—	0	0	$0
Frank Potter	Director	July 5, 2010 A	—	0	0	$0
David H. Laidley	Director	July 5, 2010 A	—	0	0	$0
Mark W Parrish	Director	July 5, 2010 A	—	0	0	$0
GOUIN SERGE	Director	July 5, 2010 A	—	0	0	$0
PAULSON & CO. INC.	10% owner	Nov. 25, 2025 P	73,255,869	1	0	$15,625,000
Bausch Health Companies Inc.	10% owner	June 1, 2022 S	310,449,643	0	0	$0
Andrew C. Von Eschenbach	—	Aug. 5, 2021 P	38,647	0	0	$0
Paul Herendeen	—	March 8, 2021 M	386,618	0	0	$0
Ryan Weldon	—	April 28, 2014 M	103,409	0	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 28 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn ×6 filings	Aug. 15, 2025	0.00%	Amendment	—	SEC
PAULSON & CO. INC. ×6 filings	Aug. 14, 2025	19.10%	Amendment	—	SEC
Alex Meruelo	April 7, 2025	9.99%	Initial filing	Passive investment	SEC
	Aug. 19, 2024	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person	May 13, 2022	—	Initial filing	—	SEC
Glenview Capital Management, LLC, Larry Robbins ×2 filings	Dec. 13, 2021	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	June 21, 2021	—	Initial filing	—	SEC
	Feb. 24, 2021	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	March 16, 2017	—	Initial filing	—	SEC
Pershing Square Capital Management, L.P., PS Management GP, LLC, William A. Ackman ×12 filings	March 14, 2017	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	June 15, 2015	—	Initial filing	—	SEC
Valeant Pharmaceuticals International, Inc., Valeant Pharmaceuticals International ×10 filings	Nov. 20, 2014	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	Sept. 25, 2014	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person	May 8, 2014	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person	May 23, 2012	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person	May 23, 2011	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person	May 11, 2011	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person	March 1, 2011	—	Initial filing	—	SEC
Undisclosed reporting person, Undisclosed reporting person	Oct. 6, 2010	—	Initial filing	—	SEC
Undisclosed reporting person	June 29, 2010	—	Initial filing	M&A / sale	SEC
Eugene Melnyk ×3 filings	March 22, 2010	—	Initial filing	—	SEC
Undisclosed reporting person	Jan. 23, 2004	—	Initial filing	—	SEC
Undisclosed reporting person	Nov. 10, 2003	—	Initial filing	—	SEC
Undisclosed reporting person	Aug. 19, 2003	—	Initial filing	—	SEC
Undisclosed reporting person	Dec. 12, 2002	—	Initial filing	—	SEC
Undisclosed reporting person	May 8, 2002	—	Initial filing	—	SEC
Undisclosed reporting person	Jan. 15, 2002	—	Initial filing	—	SEC
Undisclosed reporting person	Sept. 28, 2001	—	Initial filing	—	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 23 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
DTAN · EA Series Trust	0.28%	10,972 NS	May 29, 2026	N-PORT
TLTD · FlexShares Trust	0.09%	95,424 NS	April 30, 2026	N-PORT
ISCF · iShares Trust	0.07%	79,984 SH	Aug. 8, 2026	Daily
SCHC · SCHWAB STRATEGIC TRUST	0.05%	542,712 NS	May 31, 2026	N-PORT
DFIS · Dimensional ETF Trust	0.03%	335,303 NS	April 30, 2026	N-PORT
DXIV · Dimensional ETF Trust	0.03%	7,943 NS	April 30, 2026	N-PORT
FNDF · SCHWAB STRATEGIC TRUST	0.03%	1,414,010 NS	May 31, 2026	N-PORT
VSS · VANGUARD INTERNATIONAL EQUITY INDEX…	0.03%	978,582 SH	Aug. 8, 2026	Daily
DISV · Dimensional ETF Trust	0.03%	214,485 NS	April 30, 2026	N-PORT
PXF · Invesco Exchange-Traded Fund Trust …	0.02%	113,940 SH	Aug. 8, 2026	Daily
WSML · iShares Trust	0.01%	16,371 SH	Aug. 8, 2026	Daily
DFIC · Dimensional ETF Trust	0.01%	194,355 NS	April 30, 2026	N-PORT
IDEV · iShares Trust	0.01%	358,322 SH	Aug. 8, 2026	Daily
DFAX · Dimensional ETF Trust	0.01%	120,510 NS	April 30, 2026	N-PORT
DFSI · Dimensional ETF Trust	0.01%	10,838 NS	April 30, 2026	N-PORT
AVDE · AMERICAN CENTURY ETF TRUST	0.00%	132,116 NS	May 31, 2026	N-PORT
AVDS · AMERICAN CENTURY ETF TRUST	0.00%	2,277 NS	May 31, 2026	N-PORT
IXUS · iShares Trust	0.00%	379,782 SH	Aug. 8, 2026	Daily
DFAI · Dimensional ETF Trust	0.00%	99,833 NS	April 30, 2026	N-PORT
VXUS · VANGUARD STAR FUNDS	0.00%	3,762,192 SH	Aug. 8, 2026	Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0.00%	190,882 SH	Aug. 8, 2026	Daily
VEA · VANGUARD TAX-MANAGED FUNDS	0.00%	2,481,313 SH	Aug. 8, 2026	Daily
VSGX · VANGUARD WORLD FUND	0.00%	52,499 SH	Aug. 8, 2026	Daily

BHC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

BHC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

Moving averages & overlays

Volume

Oscillators

Momentum & trend

10-Year Performance Revenue, net income, margins and EPS trends

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Financial Health Debt, liquidity, solvency — balance sheet strength

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Dividends Yield, payout ratio, dividend history, 5Y CAGR

BHC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

12-Month Price Target

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

Institutional owners (13F) 264 filers · $1.1B total · As of June 30, 2026

Company insiders 79 insiders · 37 officers · 40 directors

Activists & 5%+ owners 28 positions

ETF ownership Held by 23 ETFs